Allspring Global Investments Holdings LLC Sells 186 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Allspring Global Investments Holdings LLC lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,670 shares of the company’s stock after selling 186 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Henry Schein were worth $413,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. First Trust Direct Indexing L.P. lifted its holdings in shares of Henry Schein by 4.2% in the first quarter. First Trust Direct Indexing L.P. now owns 5,356 shares of the company’s stock valued at $404,000 after purchasing an additional 215 shares in the last quarter. Sequoia Financial Advisors LLC grew its position in Henry Schein by 5.8% during the first quarter. Sequoia Financial Advisors LLC now owns 5,504 shares of the company’s stock worth $416,000 after buying an additional 301 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in Henry Schein by 11.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 27,894 shares of the company’s stock worth $2,186,000 after buying an additional 2,954 shares in the last quarter. BNP Paribas Financial Markets lifted its stake in shares of Henry Schein by 135.7% in the 1st quarter. BNP Paribas Financial Markets now owns 194,468 shares of the company’s stock valued at $14,686,000 after acquiring an additional 111,951 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. bought a new stake in shares of Henry Schein in the 1st quarter valued at about $234,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on HSIC. Evercore ISI increased their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. lowered their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Robert W. Baird lowered their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. Finally, StockNews.com cut Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday. Two research analysts have rated the stock with a sell rating, five have issued a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $77.50.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 1.14% of the company’s stock.

Henry Schein Trading Up 0.2 %

HSIC opened at $70.37 on Friday. The firm has a market cap of $8.92 billion, a P/E ratio of 26.06, a P/E/G ratio of 2.02 and a beta of 0.87. Henry Schein, Inc. has a 12 month low of $60.01 and a 12 month high of $82.63. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. The stock has a 50-day moving average of $70.63 and a 200 day moving average of $69.79.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.31 earnings per share. As a group, research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.